The Department of Molecular and Medical Pharmacology (DMMP) is a combined basic science and clinical department. The DMMP integrates mathematics, engineering, physical, biological and medical sciences to achieve together advances that we cannot achieve individually in three overall areas: (1) understanding biology of disease, (2) developing new molecular diagnostics and (3) developing new molecular and cellular therapeutics.

The DMMP offers an opportunity for students, postdocs, medical fellows, and basic and clinical faculty to explore together the molecular and biological mechanisms that regulate cellular and organ functions to (1) identify and understand molecular errors of disease, (2) develop means to diagnose and monitor disease, and (3) develop pharmacological means to correct these errors. The Crump Institute for Molecular Imaging (CIMI) was established by DMMP faculty. As an Organized Research Unit housed in the California NanoSystems Institute, the CIMI is a collaborative center where creative innovations and technology development in systems biology, microfluidics, nanotechnology, and molecular imaging are advancing discoveries and translating to improvement in the diagnosis and treatment of human disease.  Within the DMMP, the Ahmanson Translational Imaging Division (ATID) has both Nuclear Medicine and PET imaging research and clinical services.  Trainees have access to state-of-the-art science and technology to directly impact patient care.

There are no upcoming events for Molecular and Medical Pharmacology. View all events.